Reducing Retinal Blindness Worldwide

Alice R. McPherson RRF Research Chair at Baylor College of Medicine



Christina Y. Weng, MD, MBA
Department of Ophthalmology
Baylor College of Medicine

Dr. Weng serves as the Vitreoretinal Diseases & Surgery Fellowship Program Director at Baylor College of Medicine. Additionally, she has a faculty appointment at the Level I trauma center, Ben Taub General Hospital, in Houston.

 

Research Interests

Dr. Weng is an active investigator in numerous clinical trials, including the DRCR Retina Network trials and the AGTC Phase 1/2 intravitreal gene therapy study for X-linked retinoschisis. She leads numerous research studies in her areas of interest: macular degeneration, diabetic eye disease, healthcare economics, and telemedicine.

Having authored over 150 peer-reviewed publications and dozens of book chapters, Dr. Weng also has delivered hundreds of national and international lectures around the world. Dr. Weng is nationally renowned in her field, holding numerous leadership roles within major ophthalmology organizations such as the American Society of Retina Specialists (ASRS), Retina Society, Macula Society, American Academy of Ophthalmology (AAO), and Women in Ophthalmology.

Dr. Weng graduated cum laude from Northwestern University and then went to medical school at the University of Michigan, where she was elected to the Alpha Omega Alpha (AOA) Medical Society. While in Ann Arbor, she pursued an MBA degree from the University of Michigan’s Ross School of Business and graduated with high distinction. Dr. Weng completed her ophthalmology residency at the Wilmer Eye Institute at Johns Hopkins University in Baltimore, and surgical retina fellowship at the Bascom Palmer Eye Institute at the University of Miami.

 

Previous RRF Research Chairholder

2013-2022:  Ching-Kang Jason Chen, PhD, Department of Ophthalmology; Biochemistry and Molecular Biology; Neuroscience; Molecular and Human Genetics, Baylor College of Medicine

 

 


Change Font Size

Mission of RRF

The mission of the Retina Research Foundation is to reduce retinal blindness worldwide by funding programs in research and education. As a public charity, RRF raises funds from the private sector and the investment of its endowment funds.